Evidence map›Paper›PMID 32598229›Full record

ArticleTissue engineering. Part A2020

Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases.

Kaitlin C Fogg, Carine M Renner, Hannah Christian, Alyssa Walker, Leilani Marty-Santos, Aisha Khan, Will R Olson, Carl Parent, Andrea O'Shea, Deneen M Wellik and 2 more

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Bioengineering Approaches to Improve Gynecological Cancer Outcomes.Current opinion in biomedical engineering · 2022
    Article
  15. Multi-modal Profiling of the Extracellular Matrix of Human Fallopian Tubes and Serous Tubal Intraepithelial Carcinomas.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Kaitlin C FoggDepartment of Biomedical Engineering, University of Wisconsin - Madison, Madison, Wisconsin, USA.
Carine M RennerDepartment of Biomedical Engineering, University of Wisconsin - Madison, Madison, Wisconsin, USA.
Hannah ChristianDepartment of Biomedical Engineering, University of Wisconsin - Madison, Madison, Wisconsin, USA.
Alyssa WalkerDepartment of Biomedical Engineering, University of Wisconsin - Madison, Madison, Wisconsin, USA.
Leilani Marty-SantosDepartment of Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Aisha KhanDepartment of Biomedical Engineering, University of Wisconsin - Madison, Madison, Wisconsin, USA.
Will R OlsonDepartment of Biomedical Engineering, University of Wisconsin - Madison, Madison, Wisconsin, USA.
Carl ParentDepartment of Biomedical Engineering, University of Wisconsin - Madison, Madison, Wisconsin, USA.
Andrea O'SheaDepartment of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Deneen M WellikDepartment of Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Paul S WeismanUniversity of Wisconsin Carbone Cancer Center, and University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Pamela K KreegerDepartment of Biomedical Engineering, University of Wisconsin - Madison, Madison, Wisconsin, USA.
University of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
Engineered ECM platforms to analyze progression in high grade serous ovarian cancerR01CA232517 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI CAMPAGNOLA, PAUL J, KREEGER, PAMELA K · 2018 to 2022
$2.4M
Analysis of how quantitative cellular network variation impacts tumor progressionDP2CA195766 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI KREEGER, PAMELA K · 2014 to 2014
$2.3M
Soluble and mechanical factors directing mesothelial cell migration in clearance during ovarian cancer metastasisR21CA227922 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI KREEGER, PAMELA K, NOTBOHM, JACOB K · 2019 to 2020
$359k
NCI NIH HHS DP2 CA195766NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA232517
6 · The paper itself

Abstract

It is well known that during ovarian cancer progression, the omentum transforms from a thin lacy organ to a thick tougher tissue. However, the mechanisms regulating this transformation and the implications of the altered microenvironment on ovarian cancer progression remain unclear. To address these questions, the global and local concentrations of collagen I were determined for normal and metastatic human omentum. Collagen I was increased 5.3-fold in omenta from ovarian cancer patients and localized to areas of activated fibroblasts rather than regions with a high density of cancer cells. Transforming growth factor beta 1 (TGFβ1) was detected in ascites from ovarian cancer patients (4 ng/mL), suggesting a potential role for TGFβ1 in the observed increase in collagen. Treatment with TGFβ1 induced fibroblast activation, proliferation, and collagen deposition in mouse omental explants and an

Indexed as

Cell Line, TumorCell ProliferationCells, CulturedCollagenFemaleFibroblastsHeparin-binding EGF-like Growth FactorHumansIn Situ HybridizationOvarian NeoplasmsTransforming Growth Factor beta1CollagenHeparin-binding EGF-like Growth FactorTransforming Growth Factor beta1collagenfibroblastmicroenvironmentomentumovarian cancerTGFbeta

Identifiers

PMID32598229
PMCPMC7398436
OpenAlexW3040578777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.